Reitz, Allen Bernard
- Fox Chase Chemical Diversity Center, Inc (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #2,813
- Rising Star
- Program Leader
- Long-Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2009 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2023
Linked Award Amount
$2.4M
Full award amounts, FY2023
Award Records
2
Records listing this PI
Award-Linked Rank
#2,813
By linked amount among FY2023 PIs
Earliest Year Loaded
2009
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Reitz, Allen Bernard as a PI. Multi-PI records show the full award amount for context.
- 5U01AG068823-03U01Contact PITherapeutics targeting TDP-43 to treat Alzheimer's disease and related disorders$1.4Maward amount
- 5R42AI170552-03R42Contact PIOptimizing a Stapled-Peptide That Specifically Targets HSV-1 to Treat Herpes Ocular Keratitis$990Kaward amount
Award organization
Organizations that administered FY2023 awards listing Reitz, Allen Bernard as a PI.
FY2023 award administered by Fox Chase Chemical Diversity Center, Inc (PA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2009First NIH AwardFox Chase Chemical Diversity Center, Inc
- 2010$500K Cumulative Funding
- 2013$1M Cumulative Funding
- 2013$2M Cumulative Funding
- 2013Entered Top 50% NationallyRanked #3672
- 2013Entered Top 25% NationallyRanked #3672
- 2016Program/Center Grant Leader
- 2018$5M Cumulative Funding
- 2022$10M Cumulative Funding
- 2022Entered Top 10% NationallyRanked #1907